Cargando…

Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections

Combination antiretroviral therapy (cART) controls but does not eradicate HIV infection; HIV persistence is the principal obstacle to curing infections. The proportion of defective proviruses increases during cART, but the dynamics of this process are not well understood, and a quantitative analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, Elizabeth M., Simonetti, Francesco R., Gorelick, Robert J., Hill, Shawn, Gouzoulis, Monica A., Bell, Jennifer, Rehm, Catherine, Pérez, Liliana, Boritz, Eli, Wu, Xiaolin, Wells, Daria, Hughes, Stephen H., Rao, Venigalla, Coffin, John M., Kearney, Mary F., Maldarelli, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077288/ https://www.ncbi.nlm.nih.gov/pubmed/31991737 http://dx.doi.org/10.3390/v12020136

Ejemplares similares

No evidence of ongoing HIV replication or compartmentalization in tissues during combination antiretroviral therapy: Implications for HIV eradication
por: Bozzi, G., et al.
Publicado: (2019)

CpG Methylation Profiles of HIV-1 Proviral DNA in Individuals on ART
por: Boltz, Valerie F., et al.
Publicado: (2021)

HIV proviral DNA integration can drive T cell growth ex vivo
por: Yoon, John K., et al.
Publicado: (2020)

Lack of Detectable HIV-1 Molecular Evolution during Suppressive Antiretroviral Therapy
por: Kearney, Mary F., et al.
Publicado: (2014)

HIV‐1 proviral landscape characterization varies by pipeline analysis
por: Ferreira, Fernanda A, et al.
Publicado: (2021)

Integration in oncogenes plays only a minor role in determining the in vivo distribution of HIV integration sites before or during suppressive antiretroviral therapy
por: Coffin, John M., et al.
Publicado: (2021)

A9 A method to obtain full-length HIV proviral sequences and their sites of integration
por: Patro, Sean C, et al.
Publicado: (2019)

108. Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy
por: Gandhi, Rajesh, et al.
Publicado: (2020)

HIV Infected T Cells Can Proliferate in vivo Without Inducing Expression of the Integrated Provirus
por: Musick, Andrew, et al.
Publicado: (2019)

Droplet microfluidic sequencing of HIV proviruses with their integration sites in patients receiving antiretroviral therapy
por: Sun, Chen, et al.
Publicado: (2022)

HIV-infected cells are frequently clonally expanded after prolonged antiretroviral therapy: implications for HIV persistence
por: Maldarelli, Frank
Publicado: (2015)

The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4(+) T cells
por: Duette, Gabriel, et al.
Publicado: (2022)

Damaging the Integrated HIV Proviral DNA with TALENs
por: Strong, Christy L., et al.
Publicado: (2015)

Clinical Outcomes Following the Use of Archived Proviral HIV-1 DNA Genotype to Guide Antiretroviral Therapy Adjustment
por: Ellis, Kristen E, et al.
Publicado: (2019)

HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy
por: Omondi, F. Harrison, et al.
Publicado: (2021)

Intact Proviral DNA Analysis of the Brain Viral Reservoir and Relationship to Neuroinflammation in People with HIV on Suppressive Antiretroviral Therapy
por: Gabuzda, Dana, et al.
Publicado: (2023)

HIV-1 Proviral Transcription and Latency in the New Era
por: Shukla, Ashutosh, et al.
Publicado: (2020)

HIV proviral genetic diversity, compartmentalization and inferred dynamics in lung and blood during long-term suppressive antiretroviral therapy
por: Shahid, Aniqa, et al.
Publicado: (2022)

Role of Proviral HIV-1 DNA Genotyping for People Living with HIV (PLWH) Who Had Low-Level Viremia While Receiving Antiretroviral Therapy
por: Lv, Shiyun, et al.
Publicado: (2023)

Epigenetic modifications of HIV proviral LTRs: potential targets for cure
por: Doerfler, W, et al.
Publicado: (2012)

Differential proviral latency of the HIV-1 subtypes B and AE
por: van der Sluis, Renée M, et al.
Publicado: (2011)

Comparative HIV-1 Proviral Dynamics in Two Individuals That Maintained Viral Replication Control with or without Antiretroviral Therapy following Superinfection
por: de Azevedo, Suwellen Sardinha Dias, et al.
Publicado: (2022)

NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology
por: Wright, Imogen A., et al.
Publicado: (2021)

New Approaches to Multi-Parametric HIV-1 Genetics Using Multiple Displacement Amplification: Determining the What, How, and Where of the HIV-1 Reservoir
por: Patro, Sean C., et al.
Publicado: (2021)

Ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of HIV-1 RNA
por: Boltz, Valerie F., et al.
Publicado: (2016)

Feasibility of testing and detection of HIV-1 drug resistance in proviral DNA
por: Booth, Clare L, et al.
Publicado: (2014)

HIV-1 Tropism Determines Different Mutation Profiles in Proviral DNA
por: Nascimento-Brito, Sieberth, et al.
Publicado: (2015)

HIV-1C proviral DNA for detection of drug resistance mutations
por: Huruy, Kahsay, et al.
Publicado: (2018)

Intragenic proviral elements support transcription of defective HIV-1 proviruses
por: Kuniholm, Jeffrey, et al.
Publicado: (2021)

Clonal expansion of SIV-infected cells in macaques on antiretroviral therapy is similar to that of HIV-infected cells in humans
por: Ferris, Andrea L., et al.
Publicado: (2019)

H1N1 influenza vaccination in HIV-infected women on effective antiretroviral treatment did not induce measurable antigen-driven proliferation of the HIV-1 proviral reservoir
por: Wagner, Thor A., et al.
Publicado: (2017)

Memory CD4 + T-Cells Expressing HLA-DR Contribute to HIV Persistence During Prolonged Antiretroviral Therapy
por: Lee, Eunok, et al.
Publicado: (2019)

Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
por: Archin, NM, et al.
Publicado: (2012)

The largest HIV-1-infected T cell clones in children on long-term combination antiretroviral therapy contain solo LTRs
por: Botha, Johannes C., et al.
Publicado: (2023)

Optimizing Antiretroviral Therapy in Heavily ART-Experienced Patients with Multi-Class Resistant HIV-1 Using Proviral DNA Genotypic Resistance Testing
por: Rauschning, Dominic, et al.
Publicado: (2023)

An analytical pipeline for identifying and mapping the integration sites of HIV and other retroviruses
por: Wells, Daria W., et al.
Publicado: (2020)

Excision of HIV-1 Proviral DNA by Recombinant Cell Permeable Tre-Recombinase
por: Mariyanna, Lakshmikanth, et al.
Publicado: (2012)

The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA
por: Zhu, Weijun, et al.
Publicado: (2015)

Longitudinal comparison of HIV-1 plasma viral load and cellular proviral load
por: Schweitzer, Finja, et al.
Publicado: (2014)

Crystal structure of an engineered, HIV-specific recombinase for removal of integrated proviral DNA
por: Meinke, Gretchen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lhrjhfp48vdil7kkmhbkcji2qq